Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Celebrex

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Celebrex was produced by Pfizer.

Not in my backyard

Not in my backyard

But what happens when US wholesalers and licensed pharmacies start buying up Celebrex for less than $200 and then reselling it for a nominal discount - say $795 instead of $895?

Products over pipeline in Pfizer's acquisition targets, hints CEO

Products over pipeline in Pfizer's acquisition targets, hints CEO Most damaging to Pfizer's top-line this year was the loss of patent protection for big-selling painkiller Celebrex (celecoxib) last December in the US, with competition already being felt

Immunocore names CEO

Immunocore names CEO During this time he helped bring several drugs to markets including Celebrex (celecoxib) and Relpax (eletriptan) and to establish the company in India and China.

Pfizer 2014 guidance threatened by Celebrex competition

Pfizer 2014 guidance threatened by Celebrex competition Pfizer 2014 guidance threatened by Celebrex competition. Court overturns key patent for osteoarthritis drug. ... Celebrex sales were a little over $2.9bn last year, with $1.9bn of that total coming from the US market.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics